Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: epicure who wrote (4046)	5/10/1998 4:40:00 PM
From: Zebra 365	Read Replies (3) of 7041

RENO, Nev., Sept. 3, 1997/PRNewswire/ -- Harvard Scientific Corp. (OTC-Bulletin Board: HVSF) announced today the hiring of Irwin Goldstein, M.D. as Principal Clinical Investigator. Dr. Irwin Goldstein is Professor of Urology at Boston University School of Medicine and Co-director of Urology Research Laboratory. A graduate of Brown University and McGill University Faculty of Medicine since 1980, he has been involved in development of the field of male erectile dysfunction and has over 150 publications in that area. He has extensive experience in the pharmaceutical industry regarding drug development. He has worked with Lorenz Hofmann since 1993, including the development of a successful FDA application. Harvard Scientific Corp. is a biopharmaceutical company that is developing products relating to the lyophilized liposomal delivery of Prostaglandin E-1 (PGE-1) for treating male erectile dysfunction and impotency. Harvard Scientific Corp. has a proprietary, patented delivery system that is painless in application. The company has completed its Phase I clinical trials and is moving ahead to complete Phase II/III. >>> Dr. Goldstein gets around a bit. Zebra PS: I'm short again. {{:^) /////

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next